Top News

FDA Puts Intellia’s CRISPR Trials Under the Microscope

REGULATORY

6 Nov 2025

FDA Puts Intellia’s CRISPR Trials Under the Microscope

FDA’s hold on Intellia’s MAGNITUDE trials marks a sharper focus on CRISPR safety and long-term risk tracking

Cell and gene therapy production equipment used in CRISPR drug development

REGULATORY

15 Jan 2026

FDA opens smoother lanes for CRISPR firms

Scientist using a pipette inside a laboratory biosafety cabinet

INNOVATION

9 Jan 2026

Why Gene Editing Suddenly Feels Inevitable

Latest News

REGULATORY
15 Jan 2026
FDA opens smoother lanes for CRISPR firms
PARTNERSHIPS
13 Jan 2026
CRISPR tries to crack the rare-disease problem
INNOVATION
9 Jan 2026
Why Gene Editing Suddenly Feels Inevitable
PARTNERSHIPS
16 Dec 2025
A 2021 Gene Editing Deal Still Shapes the Future of Cancer Care

CRISPR Breakthrough Brings Gene Editing Closer to Daily Care

Scientist using pipette for gene-editing research in laboratory

INNOVATION

12 Dec 2025

New trial results suggest gene editing could move from rare use to everyday medicine, pending regulators

Branded Mammoth Biosciences packaging featuring mammoth logos arranged on a clean lab workspace.

INSIGHTS

15 May 2025

Can AI Supercharge the Battery Race?

Mammoth’s one-dose CRISPR delivery to muscle raises hopes for wider, safer genetic treatments.

4 5

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.